| CAS ID: | 956697-53-3 |
| Molecular Formula: | C26H26F3N3O3 |
| Molecular Weight: | 485.5 g/mol |
| Monoisotopic Mass: | 485.1926 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | ODOMZO | SONIDEGIB | LDE225 | ERISMODEGIB | SONIDEGIB PHOSPHATE |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C26H26F3N3O3/c1-16-14-32(15-17(2)34-16)24-12-9-20(13-30-24)31-25(33)23-6-4-5-22(18(23)3)19-7-10-21(11-8-19)35-26(27,28)29/h4-13,16-17H,14-15H2,1-3H3,(H,31,33)/t16-,17+ | See All |
| InChI Key: | VZZJRYRQSPEMTK-CALCHBBNSA-N | |
| Smiles: | C[C@@H]1CN(C[C@H](C)O1)c2ccc(NC(=O)c3cccc(c3C)c4ccc(OC(F)(F)F)cc4)cn2 | See All |
| Molfile: | Download |
Reference Record 1
Trial Record 1
| ClinicalTrial ID | NCT02151864 | Disease | Liver fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | May 30, 2014 | Last Verified | March 5, 2019 |
| Sponsor | Jason K. Sicklick, M.D. | ||
| PubChem: | 24775005 |
| ChEMBL: | CHEMBL2105737 |